(LXU) Lsb Industries - NYSE
Sector: Basic Materials | Industry: Chemicals | Exchange: NYSE (USA) | Market Cap: 878m USD | Total Return: 45.2% in 12m
Avg Turnover: 10.4M
EPS Trend: -34.3%
Qual. Beats: 2
Rev. Trend: -32.6%
Qual. Beats: 0
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
LSB Industries, Inc. (LXU) is an Oklahoma-based manufacturer of chemical products serving the agricultural and industrial sectors. Its core portfolio includes ammonia, urea ammonia nitrate, and various nitric and sulfuric acids. The company distributes these products to a diverse client base ranging from fertilizer retailers and ranchers to explosives manufacturers and industrial acid users.
Operating within the diversified chemicals sub-industry, the company’s performance is closely tied to global natural gas prices, which serve as the primary feedstock for nitrogen-based production. Demand in this sector is largely driven by agricultural planting cycles and industrial infrastructure requirements. Investors can find deeper insights into these market dynamics on ValueRay.
Founded in 1968, the company maintains a strategic focus on the U.S. grain production and ranch land markets. Its business model relies on large-scale chemical synthesis to convert raw energy inputs into essential nutrients and industrial compounds used across the domestic supply chain.
- Natural gas price volatility impacts nitrogen fertilizer production margins
- Agricultural demand for urea ammonium nitrate drives seasonal revenue cycles
- Industrial chemical sales volume correlates with domestic manufacturing output
- Shift toward blue ammonia production attracts decarbonization investment capital
- Regional fertilizer supply dynamics influence wholesale nitrogen benchmark pricing
| Net Income: 45.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 14.29 > 1.0 |
| NWC/Revenue: 33.80% < 20% (prev 34.09%; Δ -0.29% < -1%) |
| CFO/TA 0.12 > 3% & CFO 140.5m > Net Income 45.9m |
| Net Debt (338.3m) to EBITDA (164.5m): 2.06 < 3 |
| Current Ratio: 3.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (72.9m) vs 12m ago 1.49% < -2% |
| Gross Margin: 19.60% > 18% (prev 7.56%; Δ 12.04% > 0.5%) |
| Asset Turnover: 54.18% > 50% (prev 44.87%; Δ 9.31% > 0%) |
| Interest Coverage Ratio: 2.75 > 6 (EBIT TTM 81.7m / Interest Expense TTM 29.7m) |
| A: 0.18 (Total Current Assets 321.3m - Total Current Liabilities 104.6m) / Total Assets 1.19b |
| B: 0.21 (Retained Earnings 252.0m / Total Assets 1.19b) |
| C: 0.07 (EBIT TTM 81.7m / Avg Total Assets 1.18b) |
| D: 0.84 (Book Value of Equity 542.9m / Total Liabilities 648.4m) |
| Altman-Z'' = 3.23 = A |
| DSRI: 0.83 (Receivables 52.5m/51.9m, Revenue 641.3m/527.6m) |
| GMI: 0.39 (GM 7.56% / 19.60%) |
| AQI: 0.96 (AQ_t 0.00 / AQ_t-1 0.00) |
| SGI: 1.22 (Revenue 641.3m / 527.6m) |
| TATA: -0.08 (NI 45.9m - CFO 140.5m) / TA 1.19b) |
| Beneish M = -3.60 (Cap -4..+1) = AAA |
As of June 15, 2026, the stock is trading at USD 12.21 with a total of 594,775 shares traded.
Over the past week, the price has changed by -2.55%,
over one month by -15.44%,
over three months by -17.39% and
over the past year by +45.18%.
Lsb Industries has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy LXU.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.9 | 22% |
P/E Trailing = 19.381
P/E Forward = 10.2564
P/S = 1.3698
P/B = 1.6178
P/EG = 0.4225
Revenue TTM = 641.3m USD
EBIT TTM = 81.7m USD
EBITDA TTM = 164.5m USD
Long Term Debt = 440.4m USD (from longTermDebt, last quarter)
Short Term Debt = 7.96m USD (from shortTermDebt, last quarter)
Debt = 519.9m USD (from shortLongTermDebtTotal, last quarter) + Leases 35.8m
Net Debt = 338.3m USD (calculated: Debt 519.9m - CCE 181.7m)
Enterprise Value = 1.22b USD (878.4m + Debt 519.9m - CCE 181.7m)
Interest Coverage Ratio = 2.75 (Ebit TTM 81.7m / Interest Expense TTM 29.7m)
EV/FCF = 8.43x (Enterprise Value 1.22b / FCF TTM 144.4m)
FCF Yield = 11.87% (FCF TTM 144.4m / Enterprise Value 1.22b)
FCF Margin = 22.51% (FCF TTM 144.4m / Revenue TTM 641.3m)
Net Margin = 7.16% (Net Income TTM 45.9m / Revenue TTM 641.3m)
Gross Margin = 19.60% ((Revenue TTM 641.3m - Cost of Revenue TTM 515.6m) / Revenue TTM)
Gross Margin QoQ = 21.12% (prev 24.96%)
Tobins Q-Ratio = 1.02 (Enterprise Value 1.22b / Total Assets 1.19b)
Interest Expense / Debt = 5.71% (Interest Expense 29.7m / Debt 519.9m)
Taxrate = 11.70% (6.09m / 52.0m)
NOPAT = 72.2m (EBIT 81.7m * (1 - 11.70%))
Current Ratio = 3.07 (Total Current Assets 321.3m / Total Current Liabilities 104.6m)
Debt / Equity = 0.96 (Debt 519.9m / totalStockholderEquity, last quarter 542.9m)
Debt / EBITDA = 2.06 (Net Debt 338.3m / EBITDA 164.5m)
Debt / FCF = 2.34 (Net Debt 338.3m / FCF TTM 144.4m)
Total Stockholder Equity = 515.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.88% (Net Income 45.9m / Total Assets 1.19b)
RoE = 8.91% (Net Income TTM 45.9m / Total Stockholder Equity 515.8m)
RoCE = 8.55% (EBIT 81.7m / Capital Employed (Equity 515.8m + L.T.Debt 440.4m))
RoIC = 6.79% (NOPAT 72.2m / Invested Capital 1.06b)
WACC = 8.05% (E(878.4m)/V(1.40b) * Re(9.83%) + D(519.9m)/V(1.40b) * Rd(5.71%) * (1-Tc(0.12)))
Discount Rate = 9.83% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -27.98 | Cagr: -1.19%
[DCF] Terminal Value 75.44% ; FCFF base≈144.4m ; Y1≈145.0m ; Y5≈153.6m
[DCF] Fair Price = 28.50 (EV 2.39b - Net Debt 338.3m = Equity 2.05b / Shares 71.9m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: -34.32 | EPS CAGR: -22.37% | SUE: 3.00 | # QB: 2
Revenue Correlation: -32.55 | Revenue CAGR: -4.41% | SUE: 0.40 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.46 | Chg30d=-20.13% | Revisions=+0% | Analysts=2
EPS next Quarter (2026-09-30): EPS=0.36 | Chg30d=-11.04% | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=1.57 | Chg30d=+25.18% | Revisions=+0% | GrowthEPS=+172.3% | GrowthRev=+11.6%
EPS next Year (2027-12-31): EPS=1.05 | Chg30d=-12.90% | Revisions=-33% | GrowthEPS=-32.8% | GrowthRev=-4.9%
[Analyst] Revisions Ratio: -33%